Skip to Main Content

OPsumit USers Registry (OPUS)

Conditions

Diseases of the Cardiovascular System | Diseases of the Lung

What is the purpose of this trial?

Prospective observational drug registry developed to characterize the safety profile (including primarily potential serious hepatic risks) and to describe clinical characteristics and outcomes of patients newly treated with Opsumit in the post-marketing setting.

  • Trial with
    Actelion Clinical Operations, Inc.
  • Start Date
    06/28/2015
  • End Date
    09/30/2018
Trial Image

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    02/22/2018
  • Study HIC
    #1503015421REG